Changes in blood glucose levels, weight, or general wellbeing should be communicated to your healthcare team so that your overall management plan can be reviewed and adjusted as needed
For most people, their lost weight comes back
Additionally, most GLP-1s currently on the market are delivered via injection, but research and development is underway on pill-based forms
Furthermore, ongoing developments on the use of GLP-1 receptor agonists beyond diabetes in neurodegenerative diseases, cardiovascular conditions, and even obstructive sleep apnea, are propelling the global GLP-1 receptor agonist market growth
Jall S, Sachs S, Clemmensen C, Finan B, Neff F, DiMarchi RD, et al
Numbers that circulate online are often pulled from interim or early-phase results, stripped of their context, and presented as if they were established outcomes